CONNECT WITH US
Gaming

Gaming

Warhammer 40,000 Space Marine 2's New Class Is Finally Confirmed — and It's Exactly What Everyone Suspected

IGN logo

Published on

Add as a preferred source on Google
Warhammer 40,000 Space Marine 2's New Class Is Finally Confirmed — and It's Exactly What Everyone Suspected

Big news for Warhammer 40,000: Space Marine 2 fans today: publisher Focus Entertainment has revealed the game’s Year 3 roadmap and confirmed the new class set to hit early 2027.

Let’s get straight to the headline here: the new class is — as so many had suspected — the Apothecary. In May I predicted the addition of the Apothecary as a heavy duty support class with a powerful healing ability, perhaps even with unique gameplay around harvesting Gene-seed.

“We’ve been following all your speculations ever since we teased the arrival of a new class, and you certainly had plenty of theories… and the majority of you were right!” Focus said. “Today, we’re finally revealing the truth: the Apothecary is joining the ranks with Patch 17 in the first quarter of 2027! We’ll disclose more info later, so stay tuned!

“Additionally, as we said in the previous Community Update, the Apothecary will receive a Champion skin in the same way the Techmarine did: in the update after its release.”

That’s all we have on the Apothecary, unfortunately, but we have plenty more on Year 3. Patch 15 hits October 1, with Patch 16 out before the end of this year. The long-awaited Chaos Siege mode, which lets you to play Heretic Astartes previously exclusive to PvP, arrives with Patch 15, as does the One-Handed Thunder Hammer. Patch 16 adds a brand-new PvP mode featuring Weekly Stratagems, just like in PvE.

2027 will being the Apothecary, as mentioned, new Operations and weapons, and “reworks to several gameplay features, with improvements coming to some of the game’s core systems,” Focus said.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.